Significant PRAME overexpression has been described in uterine carcinosarcoma, synovial sarcoma, and multifocal leiomyosarcoma, while other sarcoma subtypes appear to express PRAME less frequently [22]. This evidence concerns the gene PRAME and sarcoma.